| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Tabuteau Herriot is a Chief Executive Officer at Axsome Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $9.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 32,410 | $185.60 | $6,015,296.00 | -81.8% | +11.1% | - | |
| Jan 7, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 139,414 | $171.30 | $23,881,617.52 | -86.5% | -1.1% | - | |
| Dec 4, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 79,973 | $145.66 | $11,648,582.34 | -78.7% | +10.8% | - | |
| Nov 5, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 163,939 | $133.07 | $21,815,669.06 | -88.3% | +38.1% | - | |
| Oct 8, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 45,384 | $119.38 | $5,418,059.86 | -67.7% | +44.8% | - | |
| Sep 16, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 62,880 | $117.08 | $7,361,891.31 | -74.4% | +28.2% | - |